[1]
|
Bilodeau, J.-F. (2013) Maternal and Placental Antioxidant Response to Preeclampsia: Impact on Vasoactive Eicosanoids. Placenta, 34, A5. https://doi.org/10.1016/j.placenta.2013.06.020
|
[2]
|
周辉, 谭译, 肖思科. 孕早期血清25羟维生素D水平与妊娠期糖尿病的相关性[J]. 医学临床研究, 2015, 32(10): 2043-2044.
|
[3]
|
李丽, 付强强. 中国妊娠期高血压疾病患病率的Meta分析[J]. 中国妇幼保健, 2019, 34(14): 3378-3381.
|
[4]
|
Ghulmiyyah, L. and Sibai, B. (2012) Maternal Mortality from Preeclampsia/Eclampsia. Seminars in Perinatology, 36, 56-59. https://doi.org/10.1053/j.semperi.2011.09.011
|
[5]
|
Hutabarat, M., Wibowo, N., Obermayer-Pietsch, B. and Hup-pertz, B. (2018) Impact of Vitamin D and Vitamin D Receptor on the Trophoblast Survival Capacity in Preeclampsia. PLOS ONE, 13, Article ID: e0206725.
https://doi.org/10.1371/journal.pone.0206725
|
[6]
|
Keane, K.N., Cruzat, V.F., Calton, E.K., Hart, P.H., Soares, M.J., Newsholme, P., et al. (2017) Molecular Actions of Vitamin D in Reproductive Cell Biology. Reproduction, 153, R29-R42. https://doi.org/10.1530/REP-16-0386
|
[7]
|
朱学创, 李利华, 尹雪艳. 维生素D和高血压发病的研究进展[J]. 中国动脉硬化杂志, 2010, 18(12): 1001-1003.
|
[8]
|
中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2020) [J]. 中华妇产科杂志, 2020, 55(4): 227-238.
|
[9]
|
余玉华, 钟春华, 刘华俭, 许明明. 妊娠中晚期子宫动脉血流阻力在子痫前期预测的临床研究[J]. 中国医学创新, 2016, 13(3): 145-148.
|
[10]
|
卢星星. 妊娠期高血压疾病早期诊断研究进展[J]. 母婴世界, 2020(18): 291-292.
|
[11]
|
Sargent, I.L., Germain, S.J., Sacks, G.P., Kumar, S. and Redman, C.W.G. (2003) Trophoblast Deportation and the Maternal Inflammatory Response in Pre-Eclampsia. Journal of Reproductive Immunology, 59, 153-160.
https://doi.org/10.1016/S0165-0378(03)00044-5
|
[12]
|
吴建凤. 不同病情程度妊娠期高血压疾病患者血清整合素β1、γ干扰素诱导蛋白16水平变化及临床意义[J]. 医学理论与实践, 2022, 35(10): 1750-70.
|
[13]
|
陈伟伟, 李伟伟, 聂红艳, 庞静, 闫娅妮. 子宫动脉彩色多普勒超声联合血清指标预测妊娠高血压发病风险的研究[J]. 河北医药, 2022, 44(9): 1357-1360.
|
[14]
|
张燕, 卫玲, 刘媛媛, 刘国栋, 梁秀文, 季新梅. 妊娠期高血压患者Tgf-β1水平及其基因rs1800469 C/T位点多态性分析[J]. 中国优生与遗传杂志, 2020, 28(6): 679-681+744.
|
[15]
|
韩懿, 司徒文慈, 雷巧茹. 妊娠早期血清25羟基维生素D水平与妊娠期高血压及疾病严重程度的相关分析[J]. 广东医科大学学报, 2019, 37(3): 256-60.
|
[16]
|
Achkar, M., Dodds, L., Giguère, Y., Forest, J.C., Armson, B.A., Woolcott, C., et al. (2015) Vitamin D Status in Early Pregnancy and Risk of Preeclampsia. American Journal of Obstetrics and Gynecology, 212, 511.e1-511.e7.
https://doi.org/10.1016/j.ajog.2014.11.009
|
[17]
|
Santorelli, G., Whitelaw, D., Farrar, D., West, J. and Lawlor, D.A. (2019) Associations of Maternal Vitamin D, Pth and Calcium with Hypertensive Disorders of Pregnancy and Associated Adverse Perinatal Outcomes: Findings from the Born in Bradford Cohort Study. Scientific Reports, 9, Article No. 1205. https://doi.org/10.1038/s41598-018-37600-9
|
[18]
|
Lee, C.L., Ng, B.K., Wu, L.L., Cheah, F.C., Othman, H. and Ismail, N.A.M. (2017) Vitamin D Deficiency in Pregnancy at Term: Risk Factors and Pregnancy Outcomes. Hormone Molecular Biology and Clinical Investigation, 31, Article ID: 20170005. https://doi.org/10.1515/hmbci-2017-0005
|
[19]
|
郝永秀. 孕期补充维生素C和(或)E预防妊娠期高血压疾病的效果及其安全性的Meta分析[D]: [硕士学位论文]. 太原: 山西医科大学, 2016.
|
[20]
|
Personnaz, J., Piccolo, E., Branchereau, M., Filliol, A., Paccoud, R., Moreau, E., et al. (2019) Macrophage-Derived Hmgb1 Is Dispensable for Tissue Fibrogenesis. FASEB BioAdvances, 1, 227-245.
https://doi.org/10.1096/fba.2018-00035
|
[21]
|
郑莉莉. 血清Hmgb1、D25-(Oh)-D和Apn与妊娠期高血压的关系[J]. 中国计划生育学杂志, 2021, 29(10): 2170-2172.
|
[22]
|
张静, 韩雪, 孙敬霞. 维生素D与妊娠期高血压疾病的相关性研究进展[J]. 中国生育健康杂志, 2020, 31(1): 84-86.
|
[23]
|
Nguyen, T.P., Yong, H.E., Chollangi, T., Borg, A.J., Brennecke, S.P. and Murthi, P. (2015) Placental Vitamin D Receptor Expression Is Decreased in Human Idiopathic Fetal Growth Restriction. Journal of Molecular Medicine, 93, 795-805. https://doi.org/10.1007/s00109-015-1267-1
|
[24]
|
Murthi, P., Yong, H.E., Ngyuen, T.P., Ellery, S., Singh, H., Rahman, R., et al. (2016) Role of the Placental Vitamin D Receptor in Modulating Feto-Placental Growth in Fetal Growth Restriction and Preeclampsia-Affected Pregnancies. Frontiers in Physiology, 7, Article No. 43. https://doi.org/10.3389/fphys.2016.00043
|
[25]
|
Caccamo, D., Cannata, A., Ricca, S., Catalano, L.M., Montalto, A.F., Alibrandi, A., et al. (2020) Role of Vitamin-D Receptor (VDR) Single Nucleotide Polymorphisms in Gestational Hypertension Development: A Case-Control Study. PLOS ONE, 15, Article ID: e0239407. https://doi.org/10.1371/journal.pone.0239407
|
[26]
|
胡馨予, 周丹, 李吉良, 蒋再英, 彭娜, 秦艳, 等. 孕妇25羟维生素D水平与妊娠高血压疾病的相关性研究[J]. 医药前沿, 2019, 9(7): 168-170.
|
[27]
|
O’Callaghan, K.M. and Kiely, M. (2018) Systematic Review of Vitamin D and Hypertensive Disorders of Pregnancy. Nutrients, 10, Article No. 294. https://doi.org/10.3390/nu10030294
|
[28]
|
亓慧敏. 血清25羟基维生素D在妊娠期高血压患者中水平及与严重程度的关系[J]. 西藏医药, 2020, 41(6): 34-36.
|
[29]
|
翟红卫, 蒋蕾. 妊娠期高血压疾病患者血清25-(Oh)D、Mpv、Hcy水平与病情程度关系[J]. 中国计划生育学杂志, 2020, 28(7): 1033-1036.
|
[30]
|
Wang, W., Du, T. and Jiang, X. (2021) Correlation between 25-Hydroxyvitamin D, Sflt-1, Plgf, and Hypertension in Pregnancy. Journal of Healthcare Engineering, 2021, Article ID: 9371953. https://doi.org/10.1155/2021/9371953
|
[31]
|
Ross, A.C., Tay-lor, C.L., Yaktine, A.L., et al. (2012) Dietary Reference Intakes for Calcium and Vitamin D. Pediatrics, 130, Article No. e1427. https://doi.org/10.1542/peds.2012-2590
|
[32]
|
World Health Organization (2012) Guideline: Vitamin D Supplementation in Pregnant Women. World Health Organization, Geneva.
|
[33]
|
Palacios, C., Kostiuk, L.K. and Pe-ña-Rosas, J.P. (2016) Vitamin D Supplementation for Women during Pregnancy. Cochrane Database of Systematic Re-views, No. 1, Article No. CD008873.
https://doi.org/10.1002/14651858.cd008873.pub4
|
[34]
|
Holick, M.F., Binkley, N.C., Bischoff-Ferrari, H.A., Gor-don, C.M., Hanley, D.A., Heaney, R.P., et al. (2011) Evaluation, Treatment, and Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 96, 1911-1930. https://doi.org/10.1210/jc.2011-0385
|
[35]
|
Serrano-Díaz, N.C., Gamboa-Delgad, E.M., Domínguez-Urrego, C.L., Vesga-Varela, A.L., Serrano-Gómez, S.E. and Quintero-Lesmes, D.C. (2018) Vitamin D and Risk of Preeclampsia: A Systematic Review and Meta-Analysis. Biomedica, 38, 43-53. https://doi.org/10.7705/biomedica.v38i0.3683
|